The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

A systematic review of 17 randomized trials found that among high cardiovascular risk individuals, reducing saturated fat was linked to lower all-cause mortality and possible reductions in ...

An announcement from Inspire Veterinary Partners, Inc. Class A ( ($IVP) ) is now available. On December 12, 2025, Inspire Veterinary Partners, ...

OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral ...

J&J has hypothesized that subcutaneous absorption of the drug may potentially enhance immune-mediated anticancer activity.

Supportive care, including intravenous immunoglobulin, may improve outcomes by reducing infection risk in patients treated ...

Fox News host Jessica Tarlov sharply responded to a new report that said Trump administration officials celebrated gutting ...

Researchers explored the effects of normal saline flush, ice packs, and magnesium sulfate compresses on incidence and severity of chemotherapy-related phlebitis.

The global internal fixation and sealants market is expected to grow at a CAGR of approximately 7% over the next five years. Market expansion is being driven by rising surgical procedure volumes, ...

Johnson & Johnson (JNJ) stock is in focus as the FDA greenlights the company's Rybrevant injectable developed with Halozyme ...

EXXUA is a novel oral selective serotonin 5HT1a receptor agonist indicated for the treatment of major depressive disorder (MDD) in adults. EXXUA is also being developed for other psychiatric disorders ...